Problem

The optical-eyewear workflow requires eye doctors, opticians, technicians, laboratories, and patients to coordinate on a single prescription pair, yet the industry has historically relied on fragmented, outdated systems built for narrow use cases. That fragmentation creates duplicate work, disconnected communication, and poor visibility across the order lifecycle. The main use case is an eye-care practice submitting a prescription lens order to a lab, then needing to verify it, track production, answer patient questions, and resolve exceptions without juggling multiple portals, phone calls, or spreadsheets.

The pain has direct economics: prescription-entry mistakes can trigger costly remakes and redos, while status inquiries consume lab customer-service capacity and manual billing creates administrative overhead and slower collections. SpecCheck targets this workflow by reducing order errors, shortening time spent waiting on or making calls, and helping labs automate invoicing and collect payments more efficiently.

Product / Service

SpecCheck is a cloud-based, optician-focused optical workflow SaaS delivered through an online dashboard. Eye-care professionals can enter prescription lens orders with built-in validations, access current product and frame information, view real-time statuses across lab partners, communicate through live chat, pay lab invoices, and provide patients with order notifications and tracking. The platform is designed to centralize ordering, status management, billing, and communication rather than replace each lab's manufacturing system.

For labs, SpecCheck integrates with the lab-management system to expose order statuses, production updates, balances, and messaging to ECP customers, while Lab Pay supports automated invoicing, reconciliation, online payments, and autopay. The ECP dashboard is available through a freemium model: order-submission functionality is free, while Pro adds broader order visibility and practice-management features at $39 per office per month, with a 14-day trial. The value proposition is fewer costly errors and calls for labs, faster and more transparent ordering for practices, and a more connected experience for patients.

Market

SpecCheck competes in optical lab-order management and broader B2B health-tech workflow SaaS, with payments and API capabilities. Its competitive set includes direct or adjacent optical lab platforms such as Rx-Universe, Optoexpert, and iZySolutions, as well as established lab-management and electronic-ordering systems such as Ocuco Innovations, DVI's VISION, OMICS, and OPTIFACTS. SpecCheck's differentiation is its independent, cross-lab ECP experience combining validated order entry, real-time tracking, communications, and billing in one modern interface, rather than a system centered only on a lab's internal production operations.

The company is an active, funded startup rather than a pre-launch product. Its public materials report more than 10,000 users or eye-care professionals, and HOYA announced in December 2025 that it would become the first lab network to offer SpecCheck, providing meaningful distribution and validation. SpecCheck is a Winter 2023 Y Combinator company, and FinSMEs reported a $3.7 million seed round led by Initialized Capital with participation from Y Combinator. GetLatka estimates $440,000 of 2025 revenue, but that figure is explicitly an estimate rather than company-reported financials, so the strongest verified traction indicators are adoption, the HOYA partnership, and the funded commercial rollout.